AIkido Pharma Announces Strategic Interest in ASP Isotopes Inc.

Provided By PR Newswire

Last update: Dec 6, 2021

NEW YORK, Dec. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company secured a strategic equity interest in ASP Isotopes, Inc., which focuses on the non-nuclear supply of enriched isotopes.